Asia · Regional markets · Korea Economic Daily

Hanmi launches Eppe, turning Korea’s obesity drug market into 3-way race with Mounjaro, Wegovy

Published by Korea Economic Daily · South Korea 19 h ago

South Korean hospitals and doctors will begin prescribing Hanmi Pharmaceutical Co.’s Eppe, the country’s first domestically developed glucagon-like ...

Read the full article on Korea Economic Daily Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.kedglobal.com)

Also worth reading

Tech in Asia

Foodpanda deploys Toku’s AI contact center in Cambodia, Laos

CNBC-TV18

Q2 Results Live Updates: Asian Paints reports earnings; Paras Defence revenue rises 42%

The Straits Times Business

Shell reports second-highest profit ever as oil refining hits record

Mint

Groww, Zerodha open US stock investing to Indians: What it means for retail investors | The risks and rewards explained

The Business Times

After Fed’s expected hold on rates, Warsh gives clear sign that hikes are coming very soon

Business Recorder